MARATTO

article · Discover Applied Sciences

Current approaches and tools for combating antibiotic resistance

20251 citationOpen accessThe University of Dodoma

Abstract

Antimicrobial resistance (AMR) is a serious global health concern that requires a wide range of strategies and tools to combat resistant pathogens successfully. Yet, there is a gap in the knowledge regarding up-to-date approaches for combating AMR. This review highlights the most effective tools and strategies for combating AMR, including vaccination, bacteriophage (phage) therapy, antibiotic stewardship, antimicrobial peptides, and development of new antibiotics. This study found that programs for antibiotic stewardship are crucial for maximizing the use of antibiotics, minimizing their misuse, and halting the development of resistance. Vaccination is also essential in averting infections, lowering the demand for antibiotics and the risk of AMR. Moreover, phage therapy provides a focused method for eliminating resistant bacteria. Broad-spectrum antimicrobial peptides show promise because they are less susceptible to resistance mechanisms and activity by bacteria. Drug delivery to infection sites can be facilitated by nanoparticles' customizable qualities, which also improve efficacy and minimize side effects. This review emphasizes how crucial it is to consider a multiple, holistic approach to effectively combat the growing threat posed by AMR.

Research topics

  • Antibiotic Use and Resistance
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s42452-025-07108-9

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.